Citigroup’s Endologix Inc ELGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-30
| Closed | – | – | 7774 |
|
|
2020
Q2 | $0 | Hold |
30
| – | – | ﹤0.01% | 7877 |
|
|
2020
Q1 | $0 | Hold |
30
| – | – | ﹤0.01% | 7975 |
|
|
2019
Q4 | $0 | Sell |
30
-1,155
| -97% | -$3.23K | ﹤0.01% | 7975 |
|
|
2019
Q3 | $5K | Sell |
1,185
-3,990
| -77% | -$23.2K | ﹤0.01% | 7374 |
|
|
2019
Q2 | $37K | Buy |
5,175
+2,376
| +85% | +$16.2K | ﹤0.01% | 6733 |
|
|
2019
Q1 | $19K | Sell |
2,799
-2,346
| -46% | -$15.5K | ﹤0.01% | 7002 |
|
|
2018
Q4 | $37K | Buy |
5,145
+3,788
| +279% | +$42.2K | ﹤0.01% | 6484 |
|
|
2018
Q3 | $26K | Buy |
1,357
+1,327
| +4,423% | +$47.4K | ﹤0.01% | 6968 |
|
|
2018
Q2 | $2K | Sell |
30
-42
| -58% | -$2.13K | ﹤0.01% | 7498 |
|
|
2018
Q1 | $3K | Sell |
72
-28
| -28% | -$1.2K | ﹤0.01% | 7330 |
|
|
2017
Q4 | $5K | Buy |
100
+44
| +79% | +$2.32K | ﹤0.01% | 7254 |
|
|
2017
Q3 | $2K | Sell |
56
-236
| -81% | -$10.8K | ﹤0.01% | 7073 |
|
|
2017
Q2 | $14K | Sell |
292
-307
| -51% | -$18.1K | ﹤0.01% | 6435 |
|
|
2017
Q1 | $43K | Sell |
599
-4,023
| -87% | -$266K | ﹤0.01% | 5805 |
|
|
2016
Q4 | $264K | Buy |
4,622
+3,908
| +547% | +$358K | ﹤0.01% | 5053 |
|
|
2016
Q3 | $91K | Buy |
714
+45
| +7% | +$5.76K | ﹤0.01% | 5269 |
|
|
2016
Q2 | $83K | Sell |
669
-4,476
| -87% | -$515K | ﹤0.01% | 5236 |
|
|
2016
Q1 | $430K | Buy |
5,145
+5,074
| +7,146% | +$418K | ﹤0.01% | 4287 |
|
|
2015
Q4 | $6K | Buy |
71
+5
| +8% | +$536 | ﹤0.01% | 7004 |
|
|
2015
Q3 | $8K | Sell |
66
-465
| -88% | -$63.1K | ﹤0.01% | 6574 |
|
|
2015
Q2 | $81K | Buy |
531
+423
| +392% | +$69.8K | ﹤0.01% | 5175 |
|
|
2015
Q1 | $19K | Sell |
108
-382
| -78% | -$57.9K | ﹤0.01% | 6129 |
|
|
2014
Q4 | $75K | Sell |
490
-231
| -32% | -$28.8K | ﹤0.01% | 5429 |
|
|
2014
Q3 | $77K | Buy |
721
+592
| +459% | +$82.5K | ﹤0.01% | 4979 |
|
|
2014
Q2 | $20K | Sell |
129
-15
| -10% | -$2K | ﹤0.01% | 5811 |
|
|
2014
Q1 | $19K | Buy |
144
+133
| +1,209% | +$20.7K | ﹤0.01% | 6067 |
|
|
2013
Q4 | $2K | Sell |
11
-2
| -15% | -$344 | ﹤0.01% | 6807 |
|
|
2013
Q3 | $2K | Sell |
13
-4
| -24% | -$630 | ﹤0.01% | 6620 |
|
|
2013
Q2 | $2K | Buy |
+17
| New | +$2.4K | ﹤0.01% | 6554 |
|
Other funds holding ELGX
Citigroup's ELGX Position: Q3 2020 in Review
Citigroup sold out of Endologix Inc (ELGX) in Q3 2020, closing a stake of 30 shares.
Citigroup first reported a position in ELGX in Q2 2013 and held it in 29 quarters. The position peaked at $430K in Q1 2016. 6 funds tracked by Wall St. Rank hold ELGX as of Q3 2020.
- Citigroup reported no remaining Endologix Inc position as of Q3 2020 after selling out during the quarter.
- Citigroup sold 30 Endologix Inc shares in Q3 2020.
- Citigroup first reported a position in Endologix Inc in Q2 2013 and held it in 29 quarters.
- Citigroup's Endologix Inc position peaked at $430K in Q1 2016.
- 6 funds tracked by Wall St. Rank held Endologix Inc as of Q3 2020.
Based on Citigroup's 13F filing for Q3 2020, filed 12 Nov 2020.